How AI Humanizes Mental Healthcare

The integration of AI into mental healthcare is more advanced than many realize because it’s not always obvious; frequently, it’s providing support to free up clinicians to spend more time with their patients or to get more patients into treatment.  The post How AI Humanizes Mental Healthcare appeared first on MedCity News.

Read More

2024 Books of the year

Below are my favorite books of the year. These are my favorite books that I read this year, not necessarily books that came out this year. On to the list! BOOK OF THE YEAR Nature’s Metropolis: Chicago and the Great West by William Cronon. I learned so much from this book. It discusses the development…

Read More

Tatiana Fofanova demos Koda Health

Tatiana Fofanova is the CEO of Koda Health. She is dealing with one of the most difficult parts of health care. How do you get patients wishes in the case of end of life or other critical illness made in advance and delivered to medical professionals? Koda Health has not only figured out how to…

Read More

Tracking State Rural Health Transformation Plans

The five-year, $50 billion Rural Health Transformation program was created as part of the One Big Beautiful Bill Act to expand access to healthcare. States competed to win funding with first-year allocations ranging from $147 million for New Jersey to $281 million for Texas. Find links to available public documents for each state below. KFF…

Read More

NHS England will be abolished

As reported by the BBC: NHS England will be abolished and brought under “democratic control” in an attempt to cut bureaucracy and duplication, Sir Keir Starmer has announced. The organisation, which oversees the country’s health service, will be brought into the Department of Health, and the PM said the move would free up money for…

Read More

Links

UK medicines regulator needs more resources.Big money for biosimilars.Fixing liberalism.2024 scientific breakthroughs.The Economist: Best books of 2024.

Read More

Novo Nordisk Lands Lexicon Pharma Obesity Drug With Potential to Pair With GLP-1s

Novo Nordisk gets global rights to Lexicon Pharmaceuticals’ LX9851, an oral small molecule with a first-in-class approach to sparking weight loss. The licensing agreement comes months after Lexicon reported encouraging preclinical data from tests of LX9851 in combination with semaglutide, the main ingredient in Novo Nordisk’s Wegovy. The post Novo Nordisk Lands Lexicon Pharma Obesity…

Read More